Pulmonary Medicine
Currently calling for submissions for the 2021 volume for the following article types: Original Research, Study Characteristics, Clinical Studies, Systematic Reviews, Reviews, Mini Reviews, Case Series, and Commentaries.
In the Pulmonary Medicine section, we consider for publication the latest advances in:
|
Alpha-1 antitrypsin deficiency |
Interstitial Lung Disease (ILD) |
|
Asthma |
Lung cancer |
|
Chronic Obstructive Pulmonary Disease (COPD) |
Lung physiopathology |
|
Cystic fibrosis |
Respiratory failure |
|
Emphysema |
Sleep apnea |
|
Infectious diseases |
Annals of Medicine
Q1 Impact Factor Best Quartile
Two-Year Impact Factor 4.709
Five-Year Impact Factor 4.554
CiteScore 7.2
PubMed Central® and MEDLINE® Indexed
Meet the Section Editor
Laura Pini, MD, Professor of Respiratory Medicine, Department of Clinical and Experimental Sciences, University Hospital of Brescia, Italy
Professor Pini completed her Post-Doc at the Meakins Christie Laboratory, McGill University, Canada in 2005 where her research primarily focused on airway remodeling. Pini's research interests include lung pathophysiology, airway remodeling, severe asthma and alpha-1 antitrypsin deficiency. Pini has contributed to several national and international pharmacological studies and published more than 100 peer-reviewed articles. Professor Pini is currently an active member of the European Respiratory Society, the European Alpha-1 antitrypsin deficiency Award (e-ALTA) Network, the Severe Asthma Network in Italy (SANI) and the Severe Heterogenous Asthma Research (SHARP) Clinical Research Collaboration. Pini also lectures and supervises medical residents enrolled in the University's Respiratory Medicine Program.
Why is Annals of Medicine the best publication for your research?
|
Fully open access, general medical journal publishing articles under a CC BY license, allowing maximum sharing and reuse of articles to our international readership; |
|
Publishing all scientifically valid research, including reporting of negative and null data, from translational to clinical research in all disciplines and therapy areas; |
|
Led by an international editorial team of subject experts who ensure a constructive and rigorous peer review process; |
|
Your research is promoted via a tailored, multi-channel approach to maximize visibility, readership and impact. |
Editing Services
To help improve your manuscript and prepare it for submission, Taylor & Francis provides a range of editing services such as English Language Editing, which will ensure that your article is free of spelling and grammar errors, Translation, and Artwork Preparation.